Posted 3/9/2024, 11:15:00 PM
FDA Grants Breakthrough Status to MindMedicine's LSD Therapy Showing Promise for Anxiety and Depression
- FDA grants breakthrough status to MindMedicine's MM120, an LSD therapy for anxiety and depression
- Single dose provided relief for 65% of patients in trial, more than double standard treatments
- Works faster than therapy/meds, with no need for dose adjustments or added therapy
- First study showing LSD can effectively treat anxiety with no psychotherapy
- Designation expected to bring MindMedicine $175 million in investments for Phase 3 trials
